Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 68.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 364,665 shares of the pharmacy operator’s stock after selling 778,230 shares during the quarter. Victory Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $3,267,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Redwood Investment Management LLC grew its stake in shares of Walgreens Boots Alliance by 0.9% in the 1st quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock valued at $2,162,000 after buying an additional 850 shares in the last quarter. Inlet Private Wealth LLC boosted its holdings in Walgreens Boots Alliance by 1.9% in the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock valued at $578,000 after acquiring an additional 900 shares during the last quarter. Capital Investment Counsel Inc boosted its holdings in Walgreens Boots Alliance by 6.6% in the second quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock valued at $186,000 after acquiring an additional 950 shares during the last quarter. Continuum Advisory LLC boosted its holdings in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in Walgreens Boots Alliance by 1.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock worth $795,000 after buying an additional 1,038 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $8.66 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $27.05. The business has a 50-day simple moving average of $9.14 and a two-hundred day simple moving average of $11.55. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The stock has a market cap of $7.49 billion, a PE ratio of -0.87, a PEG ratio of 1.09 and a beta of 0.69.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same quarter in the previous year, the company posted $0.67 EPS. The business’s revenue was up 5.9% on a year-over-year basis. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 11.55%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on WBA shares. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Barclays boosted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Bank of America reduced their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. UBS Group boosted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Finally, TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.